This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: hypertension

Renal denervation for hypertension: where are we now?

December 2013 Br J Cardiol 2013;20:142–7 doi:10.5837/bjc.2013.33

Renal denervation for hypertension: where are we now?

Hitesh C Patel, Carlo di Mario

Abstract

(more…)

| Full text

March 2013 Br J Cardiol 2013;20:37

Book reviews

Abstract

Rather than a structured textbook this is a collection of individual essays, some of which are very useful and interesting, and some not quite so good. There are 38 contributors for 18 chapters. Compiled for doctors ranging from the internist to the specialist, it is very much an American text. Outside of the US it will arouse the curiosity of those of us interested in hypertension, more in terms of an insight into the current thoughts of our American cousins. One particular insight is the recommendation to do urine spot tests for sodium and potassium levels, to check adherence to the Dietary Approaches to Stop Hypertension (DASH) diet, with

| Full text
Optimising hypertension treatment: NICE/BHS guideline implementation and audit for best practice

March 2013 Br J Cardiol 2013;20(suppl 1): S1–S16 doi:10.5837/bjc.2013.s01

Optimising hypertension treatment: NICE/BHS guideline implementation and audit for best practice

Dr Terry McCormack, Dr Chris Arden, Dr Alan Begg, Professor Mark Caulfield, Dr Kathryn Griffith, Ms Helen Williams

Abstract

(more…)

| Full text

November 2012 Br J Cardiol 2012;19:151 doi:10.5837/bjc.2012.028

BHS call for more primary care and cardiologist members

Tony Heagerty, Terry McCormack

Abstract

Activities The Society has been instrumental in developing guidelines for the management of hypertension, which have been modified on a variety of occasions. In particular, we have interacted with the National Institute for Health and Clinical Excellence (NICE) on their last two guidelines. Both the BHS and NICE guidelines are looked upon as highly influential worldwide. We have also successfully lobbied Government in respect to reducing dietary salt in foodstuffs. It is likely that more stringent Quality Outcome Framework blood pressure treatment targets will be introduced next year as a direct result of the Society’s influence. BHS Member

| Full text
News from the American College of Cardiology Scientific Session 2012

May 2012 Br J Cardiol 2012;19:59–61

News from the American College of Cardiology Scientific Session 2012

News from the world of cardiology

Abstract

CORONARY: off-pump and on-pump CABG similar The largest trial ever to compare off-pump and on-pump coronary artery bypass surgery (CABG) has shown no difference between the two techniques in terms of the primary composite end point. There were, however, some differences in certain end points, leading to the suggestion that the decision as to which approach to choose could be individualised with each patient. Table 1. Main results from the CORONARY trial The CORONARY trial enrolled 4,752 patients who were randomised to off-pump or on-pump surgery. At 30 days the primary end point – a composite of death, myocardial infraction (MI), kidney fai

| Full text
In brief

March 2012 Br J Cardiol 2012;19:12–3

In brief

BJCardio Staff

Abstract

NICE updates A new ‘Evidence Update’ has been produced by the National Institute for Health and Clinical Excellence (NICE), which summarises selected new evidence relevant to the NICE guideline on the management of chronic heart failure (CHF) in adults in primary and secondary care (clinical guideline 108).NICE says “Whilst Evidence Updates do not replace current accredited guidance, they do highlight new evidence that might generate a future changes in practice.”  It says it will welcome feedback from societies and individuals in developing this service. The update is available from www.evidence.nhs.uk/evidence-update-2. New guides

| Full text

March 2012 Br J Cardiol 2012;19:16

Cardiovascular disease – everyday management

Abstract

Every day practice This year’s meeting examined the importance of both pulse and blood pressure in everyday clinical practice. Professor Tom McDonald (University of Dundee), Vice President of the BHS, welcomed delegates to the symposium on blood pressure and vascular disease, held in conjunction with the BHS. Current interest in the subject results from the publication last year of National Institute for Health and Clinical Excellence (NICE) clinical guideline 127 on the clinical management of primary hypertension in adults, and its recommended approach to hypertension diagnosis and blood pressure management.1 The first speaker, Professor M

| Full text

October 2011 Br J Cardiol 2011;18:203

Changes to hypertension guidelines

BJCardio Staff

Abstract

Key new recommendations include the following: Diagnosis of primary hypertension should be confirmed using 24–hour ambulatory blood pressure monitoring, or home blood pressure monitoring, rather than be based solely on measurements of blood pressure taken in the clinic. This is to reduce the occurrence of white coat hypertension, which recent studies have suggested is causing the misdiagnosis of hypertension in up to a quarter of the 12 million patients currently labeled with the condition. For the treatment of hypertension, the guideline now recommends that calcium channel blockers (CCBs) should be the first choice of agent used in patien

| Full text
Quality in CVD care – taking the lead in the new NHS

October 2011 Br J Cardiol 2011;18:212-213

Quality in CVD care – taking the lead in the new NHS

BJCardio Staff

Abstract

Navigating the changing landscape of cardiovascular commissioning A clear majority (58%) of GPs with a special interest in cardiology (GPSIs) feel unprepared to fulfill a commissioning role in the new NHS landscape, despite almost half of GPs being currently involved in commissioning, according to results from the REACCT (REAssessing Cardiology Commissioning and Treatment) report announced at the meeting. The report also reveals that a majority of cardiologists (57%) feel unprepared to take on new commissioning roles around the management of cardiovascular disease (CVD). The report (available from: www.pccs.org.uk/report) was written by the P

| Full text
News from the American College of Cardiology Scientific Session 2011

June 2011 Br J Cardiol 2011;18:105–8

News from the American College of Cardiology Scientific Session 2011

BJCardio Staff

Abstract

PARTNER: transcatheter valves just as good as surgery for high risk aortic stenosis Transcatheter aortic valve implantation (TAVI) is just as effective at reducing mortality as surgery for severe aortic stenosis in elderly patients whose age and overall health posed high risks for conventional surgery, according to the results of the PARTNER (Placement of AoRTic TraNscathetER Valve trial). However, stroke rates were higher in the trancatheter group. The transcatheter approach involves delivering a bioprosthetic valve to its target location with a catheter using either transfemoral access or trans-apical access (through the ribs) if peripheral

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now